Skip Navigation Links
ScientificNameLabel
Androstane-11,17-dione,3-[(trimethylsilyl)oxy]-,17-[O-(phenylmethyl)oxime],(3alpha,5alpha)
PHCD compound ID : 5106
Chemical Names :
Androstane-11,17-dione,3-[(trimethylsilyl)oxy]-,17-[O-(phenylmethyl)oxime],(3alpha,5alpha)
Molecular Formula : C29H43N1O3Si1
Molecular Weight : 481.301221
More Details :
Names & Synonyms: (3R,5S,8S,9S,10S,13S,14S,17E)-17-benzyloxyimino-10,13-dimethyl-3-trimethylsilyloxy-2,3,4,5,6,7,8,9,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-11-one , (3R,5S,8S,9S,10S,13S,14S,17E)-10,13-dimethyl-17-phenylmethoxyimino-3-trimethylsilyloxy-2,3,4,5,6,7,8,9,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-11-one , (3R,5S,8S,9S,10S,13S,14S,17E)-10,13-dimethyl-17-phenylmethoxyimino-3-trimethylsilyloxy-2,3,4,5,6,7,8,9,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-11-one , (3R,5S,8S,9S,10S,13S,14S,17E)-17-benzyloximino-10,13-dimethyl-3-trimethylsilyloxy-2,3,4,5,6,7,8,9,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-11-one
Smiles: O=C1C[C@]2(C)/C(=N/OCc3ccccc3)/CC[C@H]2[C@H]2[C@H]1[C@@]1(C)CC[C@H](C[C@@H]1CC2)O[Si](C)(C)C
InChi : InChI=1S/C29H43NO3Si/c1-28-16-15-22(33-34(3,4)5)17-21(28)11-12-23-24-13-14-26(29(24,2)18-25(31)27(23)28)30-32-19-20-9-7-6-8-10-20/h6-10,21-24,27H,11-19H2,1-5H3/b30-26+/t21-,22+,23-,24-,27+,28-,29-/m0/s1
InChi Key : InChIKey=TYMQXPHAFNHDNL-SOMKEMBRSA-N
PubChem ID : 20845500
Rotatable bond count : 5 Rule of five : 1
Hydrogen bond acceptor count : 2 Ionization potential : 9.427242
Hydrogen bond donor count : 0 Electric dipole moment : 3.078
XLogP : 6.078 VDW volume : 497.15171
Molecular weight : 481.301221 HOMO-LUMO gap : 9.430000
Herb list :
Refrences & Litretures:
  
806.      Journal:'Immunopharmacology and Immunotoxicology'      Year:'2012'      Volume:'34'      Page:'205'      DOI:'10.3109/08923973.2011.592534'      Title:'Chemical composition, antioxidant activity and larvicidal efects of essential oil from leaves of Apium graveolens'
Copyright © 2017, Chemistry and Chemical Engineering Research Center of Iran. All rights reserved.
Follow us